Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002304 · ClinicalTrials.gov registry record · NA
A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems
A NA study of HIV Infections and Candidiasis, Esophageal, sponsored by Pfizer.
- Completed
- Registry status
- NA
- Development phase
- 20
- Study locations
NCT00002304 is a NA study of HIV Infections and Candidiasis, Esophageal that has completed, run by Pfizer. The trial reports 20 study locations across 7 states.
The verdict
NCT00002304, a NA study of HIV Infections and Candidiasis, Esophageal, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- NA
- Development phase
- 20
- Study locations
Study Summary
To compare the safety, tolerance, and effectiveness of fluconazole and ketoconazole in the treatment of candidal esophagitis in immunocompromised patients.
Conditions Studied
Interventions
- DRUG Fluconazole
- DRUG Ketoconazole
Study Locations (20)
Georgia
- Georgia Baptist Med Ctr - Atlanta
- DeKalb Gen Hosp - Decatur
- Gwinnett Med Ctr - Lawrenceville
- Atlanta Hosp - Riverdale
- Clayton Gen Hosp - Riverdale
- Dr Winkler Weinberg - Roswell
Florida
- Regional Oncology Ctr - Daytona Beach
- Ctr for Special Immunology - Fort Lauderdale
- Mem Hosp Hollywood - Hollywood
- Med Ctr Clinic - Pensacola
- St Petersburg Med Clinics - St. Petersburg
California
- Los Angeles County - USC Med Ctr - Los Angeles
- Eisenhower Med Ctr - Rancho Mirage
- ViRx Inc - San Francisco
- UCSF Hosp - San Francisco
Massachusetts
- Univ Hosp - Boston
- Baystate Med Ctr of Springfield - Springfield
Arizona
- Good Samaritan Med Ctr - Phoenix
Arkansas
- Arkansas Children's Hosp - Little Rock
District of Columbia
- George Washington Univ Med Ctr - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002304
The ClinicalTrials.gov registry entry for NCT00002304 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Fluconazole is the first listed.
NCT00002304 reports 20 study locations spanning 7 distinct geographic areas - top geographies include Georgia, Florida, California.
Frequently Asked Questions
What is clinical trial NCT00002304 about?
NCT00002304 is a clinical study titled "A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems". To compare the safety, tolerance, and effectiveness of fluconazole and ketoconazole in the treatment of candidal esophagitis in immunocompromised patients.
What is the current status of trial NCT00002304?
This trial is currently completed. It is a NA study.
What conditions does trial NCT00002304 study?
This clinical trial studies the following conditions: HIV Infections, Candidiasis, Esophageal.
What interventions are being tested in trial NCT00002304?
The interventions under investigation include: Fluconazole (DRUG), Ketoconazole (DRUG).
Who is sponsoring clinical trial NCT00002304?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00002304 being conducted?
This trial has 20 study locations across Arizona, Arkansas, California, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.